U.S. market Closed. Opens in 6 hours

EPIX | ESSA Pharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue118.49K121.79K109.46K110.32KN/AN/AN/AN/AN/AN/A
Gross Profit-118.49K-121.79K-109.46K-110.32KN/AN/AN/AN/AN/AN/A
Operating Expenses32.13M36.96M37.14M23.52M12.17M10.80M10.87M18.70M9.23MN/A
Selling, General & Admin11.37M12.54M12.78M11.37M5.47M5.93M5.09M5.58M3.70M1.04M
Research & Development21.32M24.41M24.26M12.15M6.70M4.87M5.73M13.06M4.39M671.60K
Other Operating ExpensesN/A1.74M109.46K515.00K35.00K-40.00K46.15K66.18K1.15MN/A
Operating Income-26.58M-35.34M-36.91M-23.12M-12.15M-10.80M-11.65M-18.70M-9.23M-1.74M
Other Expenses / Income6.53K127.79K68.76K-618.68K1.75M111.00K7.27M5.72M665.98K-86.98K
Before Tax Income-26.58M-35.22M-36.84M-23.73M-10.40M-11.60M-4.38M-12.99M-8.57M-1.82M
Income Tax Expenses1.60K-112.00K-34.35K-289.00K38.00K27.00K340.76K151.27KN/AN/A
Net Income-26.58M-35.10M-36.81M-23.45M-10.44M-11.63M-4.72M-13.14M-8.57M-1.82M
Interest Expenses6.94K14.00K22.22K618.00K603.00K912.00K784.58K937.85K77.77K87.59K
Basic Shares Outstanding44.09M44.04M38.48M22.44M8.43M4.57M1.45M1.35M917.65K784.38K
Diluted Shares Outstanding44.09M44.04M38.48M22.44M8.43M4.57M1.45M1.35M917.65K784.38K
EBITDA-26.46M-35.22M-36.80M-23.00M-12.13M-10.84M-10.82M-18.64M-9.20M-1.71M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-26.57M-35.20M-36.82M-23.12M-9.80M-10.69M-3.60M-12.05M-8.49M-1.74M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙